Risk of Heart Inflammation Remains Elevated After COVID-19 Booster: Study

Click here to read the full article.

The risk of heart inflammation following receipt of a COVID-19 booster shot remains elevated, according to a new study.

The primary series of the messenger RNA-based vaccines, made by Pfizer and Moderna, have already been linked to heart inflammation, but not as much research has been done on whether booster doses also present heart-related risks.

In the study, French researchers analyzed 4,890 myocarditis cases admitted to hospitals in the country between Dec. 27, 2020, and Jan. 31, 2022. They used 48,900 controls from the general population, matching for gender, age, and area of residence.

Receipt of a COVID-19 vaccine booster was found to result in an elevated risk of myocarditis, a type of heart inflammation, particularly receipt of a Moderna booster.

Continue reading here.

Scroll down for comments and share your thoughts!

What do you think?

Leave a Reply

Your email address will not be published.

GIPHY App Key not set. Please check settings

Biden expected to extend Covid emergency through 2024 elections

WATCH: Biden admin says US 'in a transition' not a recession